SCHOLARLY PUBLICATION

Antibody–drug conjugates come of age in oncology

Charles Dumontet, Janice M. Reichert, Peter D. Senter, John M. Lambert, Alain Beck

📖 Nature Reviews Drug Discovery → 📅 2023-06-12 🔗 DOI: 10.1038/s41573-023-00709-2

View Journal Profile → View Official Paper ↗

📄 Abstract

The abstract has not yet been added. Use the official source link for the complete publication record.

ℹ️ Publication Details

Journal: Nature Reviews Drug Discovery
Published: 2023-06-12
DOI: 10.1038/s41573-023-00709-2
OpenAlex: W4380320004
Access: Via publisher

📋 Cite This Paper

Charles Dumontet, Janice M. Reichert, Peter D. Senter, John M. Lambert, Alain Beck (2023). Antibody–drug conjugates come of age in oncology. Nature Reviews Drug Discovery. https://doi.org/10.1038/s41573-023-00709-2

🔬 Related Research Papers

Nature Reviews Drug Discovery

Mining the Wnt pathway for cancer therapeutics

Nick Barker, Hans C. Clevers 2006-12-01 · Read paper → Nature Reviews Drug Discovery

The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics

Eric H. Karran, Bart De Strooper 2022-02-17 · Read paper → Nature Reviews Drug Discovery

NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential

Oleg V. Evgenov, Pál Pacher et al. 2006-09-01 · Read paper → Nature Reviews Drug Discovery

Therapeutically harnessing extracellular vesicles

Lesley Cheng, Andrew Francis Hill 2022-03-02 · Read paper → Nature Reviews Drug Discovery

Signalling bias in new drug discovery: detection, quantification and therapeutic impact

Terry Kenakin, Arthur Christopoulos 2012-02-15 · Read paper → Nature Reviews Drug Discovery

The drug–target residence time model: a 10-year retrospective

Robert A. Copeland 2015-12-18 · Read paper → Nature Reviews Drug Discovery

Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases

Robert A. Casero, Laurence J. Marton 2007-04-27 · Read paper → Nature Reviews Drug Discovery

Drugging p53 in cancer: one protein, many targets

Ori Hassin, Moshe Oren 2022-10-10 · Read paper → Nature Reviews Drug Discovery

Reducing safety-related drug attrition: the use of in vitro pharmacological profiling

Joanne Bowes, Andrew J. Brown et al. 2012-11-30 · Read paper → Nature Reviews Drug Discovery